Ascentage Pharma Group International
(NASDAQ) AAPG
Ascentage Pharma Group International Financials at a Glance
Market Cap
$1.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CN¥1.55B
Net Income (TTM)
-CN¥1.64B
EPS (TTM)
-$1.94
P/E Ratio
-9.53
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$19.37
Volume
12,914.163
Open
$18.57
Price
$19.37
Volume
12,914.163
Open
$18.57
Previous Close
$19.37
Daily Range
$18.52 - $19.41
52-Week Range
$16.36 - $48.45
Estimated Earnings Date
Aug 26, 2026
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$19.37
Volume
12,914.163
Open
$18.57
Previous Close
$19.37
Daily Range
$18.52 - $19.41
52-Week Range
$16.36 - $48.45
Estimated Earnings Date
Aug 26, 2026
AAPG News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ascentage Pharma Group International
Industry
Biotechnology
Sector
Health CareEmployees
767
CEO
Da Jan Yang, MD, PhD
Website
www.ascentage.comHeadquarters
Suzhou, JS 215000, CN
AAPG Financials
Key Financial Metrics (TTM)
Gross Margin
84.09%
Operating Margin
-210.42%
Net Income Margin
-216.74%
Return on Equity
-123.61%
Return on Capital
-35.66%
Return on Assets
-31.03%
Earnings Yield
-10.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
93.00M
Volume
12.91K
Avg. Volume
10.40K
Financials (TTM)
Gross Profit
CN¥1.43B
Operating Income
-CN¥1.57B
EBITDA
-CN¥1.41B
Operating Cash Flow
-CN¥1.32B
Capital Expenditure
-CN¥52.07M
Free Cash Flow
-CN¥1.38B
Cash & ST Invst.
CN¥2.47B
Total Debt
CN¥1.98B
Ascentage Pharma Group International Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥334.13M
+321.4%
Gross Profit
CN¥265.45M
+296.8%
Gross Margin
79.44%
N/A
Market Cap
$1.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.03M
N/A
Employees
567
N/A
Net Income
-CN¥639.96M
-22.3%
EBITDA
-CN¥598.95M
-21.6%
Quarterly Fundamentals
Total Cash
CN¥2.47B
+131.1%
Total Debt
CN¥1.98B
+10.3%
Accounts Receivable
CN¥253.10M
+54.8%
Inventory
CN¥28.64M
+77.1%
Long Term Debt
CN¥757.72M
-35.7%
Short Term Debt
CN¥1.22B
+98.5%
Return on Assets
-31.03%
N/A
Return on Invested Capital
-51.46%
N/A
Free Cash Flow
-CN¥787.41M
-113.0%
Operating Cash Flow
-CN¥779.66M
-118.0%